Candel Therapeutics Ownership | Who Owns Candel Therapeutics?
Candel Therapeutics Ownership Summary
Candel Therapeutics is owned by 20.91% institutional investors, 30.39% insiders, and 48.71% retail investors. Northpond ventures is the largest institutional shareholder, holding 6.63% of CADL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.69% of its assets in Candel Therapeutics shares.
CADL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Candel Therapeutics | 20.91% | 30.39% | 48.71% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Northpond ventures | 1.94M | 6.63% | $12.00M |
Blackrock | 823.07K | 2.82% | $5.10M |
Vanguard group | 818.55K | 2.80% | $5.08M |
State street | 472.80K | 1.62% | $2.93M |
Sands capital ventures | 405.84K | 1.39% | $2.52M |
Geode capital management | 397.89K | 1.36% | $2.47M |
Nuveen asset management | 382.19K | 1.31% | $2.37M |
Bridgeway capital management | 80.59K | 0.28% | $499.69K |
Mml investors services | 73.38K | 0.25% | $455.00K |
Bank of america corp /de/ | 54.45K | 0.19% | $337.58K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Northpond ventures | 1.94M | 21.71% | $12.00M |
Sands capital ventures | 405.84K | 0.84% | $2.52M |
Bridgeway capital management | 80.59K | 0.01% | $499.69K |
Virtu financial | 22.64K | 0.01% | $140.00K |
Mml investors services | 73.38K | 0.00% | $455.00K |
Cubist systematic strategies | 26.12K | 0.00% | $161.95K |
Nuveen asset management | 382.19K | 0.00% | $2.37M |
Corebridge financial | 10.66K | 0.00% | $66.20K |
Vontobel | 22.00K | 0.00% | $136.40K |
Ameritas investment partners | 1.94K | 0.00% | $12.03K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 823.07K | 0.00% | 775.49K |
State street | 472.80K | 0.00% | 445.20K |
Nuveen asset management | 382.19K | 0.00% | 382.19K |
Vanguard group | 818.55K | 0.00% | 277.25K |
Geode capital management | 397.89K | 0.00% | 252.18K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Sands capital ventures | 405.84K | 0.84% | -405.90K |
Mariner | - | - | -33.48K |
Resources investment advisors, llc. | - | - | -29.78K |
Advisor group | - | - | -25.80K |
Schonfeld strategic advisors | - | - | -21.45K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Nuveen asset management | 382.19K | 0.00% | 382.19K | $2.37M |
Mml investors services | 73.38K | 0.00% | 73.38K | $455.00K |
Bank of new york mellon | 54.45K | 0.00% | 54.45K | $337.58K |
Charles schwab investment management | 46.78K | 0.00% | 46.78K | $290.02K |
Cubist systematic strategies | 26.12K | 0.00% | 26.12K | $161.95K |
Sold Out
Holder | Change |
---|---|
Qube research | -1.00 |
Point72 asia (singapore) pte. | -813.00 |
Point72 (difc) | -4.93K |
Two sigma investments, lp | -13.41K |
Commonwealth equity services | -14.18K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 56 | 14.29% | 6,693,231 | 12.27% | 20 | 5.01% | 31 | -26.19% | 10 | 150.00% |
Jun 30, 2024 | 49 | 157.89% | 5,961,761 | 57.71% | 20 | 11.96% | 42 | 366.67% | 4 | -20.00% |
Mar 31, 2024 | 19 | -9.52% | 3,780,258 | -6.13% | 13 | 6.74% | 9 | - | 5 | - |
Dec 31, 2023 | 21 | 10.53% | 4,027,160 | -23.41% | 13 | 4.21% | 9 | 50.00% | 5 | - |
Sep 30, 2023 | 19 | - | 5,257,852 | -2.09% | 18 | 5.27% | 6 | 20.00% | 5 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 543.64K | 1.69% | 89.83K |
iShares Russell 2000 ETF | 511.78K | 1.60% | -1.15K |
BANOR SICAV Rosemary S EUR Acc | 398.83K | 1.24% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 220.07K | 0.69% | - |
State St Russell Sm/Mid Cp® Indx NL Cl C | 218.40K | 0.68% | -4.10K |
Fidelity Small Cap Index | 203.68K | 0.63% | -5.77K |
iShares Russell 2000 Growth ETF | 178.36K | 0.56% | - |
Aesculape SRI IC | 135.75K | 0.42% | - |
Fidelity Extended Market Index | 114.33K | 0.36% | 24.40K |
Vanguard US Momentum Factor ETF | 97.22K | 0.30% | 97.22K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 16, 2024 | Manning Paul B | - | Buy | $4.50M |
Dec 16, 2024 | Manning Paul B | - | Buy | $3.00M |
Nov 29, 2024 | Tyagarajan Seshu | Chief Technology Officer | Sell | $92.90K |
Nov 29, 2024 | Tak Paul Peter | Chief Executive Officer | Sell | $222.53K |
Nov 29, 2024 | Nichols William Garrett | Chief Medical Officer | Sell | $63.48K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 2 | 10 |
2024 Q3 | - | 10 |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
CADL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools